Skip to main content

Table 2 ER and clinical and ultrasound features in Group I from the training set

From: Application of preoperative ultrasound features combined with clinical factors in predicting HER2-positive subtype (non-luminal) breast cancer

Clinical and ultrasound features

Group I

Univariate analysis

ER− (PR−, HER2−)

(N = 194)

ER+ (PR−, HER2−)

(N = 62)

X2 value

P value

Age (year)

  

3.719

0.054

 ≤ 50

83 (42.8)

18 (29.0)

  

 > 50

111 (57.2)

44 (71.0)

  

Palpable ALN

  

0.818

0.366

 No

149 (76.8)

51 (82.3)

  

 Yes

45 (23.2)

11 (17.7)

  

US ALN

  

0.979

0.323

 No

105 (54.1)

38 (61.3)

  

 Yes

89 (45.9)

24 (38.7)

  

Breast cancer family history

  

0.391

0.534

 No

184 (94.8)

60 (96.8)

  

 Yes

10 (5.2)

2 (3.2)

  

Menopause

  

2.374

0.123

 No

84 (43.3)

20 (32.3)

  

 Yes

110 (56.7)

42 (67.7)

  

BMI (kg/m2)

  

2.979

0.225

 < 18

3 (1.5)

3 (4.8)

  

 18–24

119 (61.4)

33 (53.2)

  

 > 24

72 (37.1)

26 (42.0)

  

Tumor size (mm)

  

1.958

0.162

 ≤ 20

29 (14.9)

14 (22.6)

  

 > 20

165 (85.1)

48 (77.4)

  

Shape

  

8.255

0.016*

 Oval

28 (14.4)

1 (1.6)

  

 Round

7 (3.6)

4 (6.5)

  

 Irregular

159 (82.0)

57 (91.9)

  

Orientation

  

2.049

0.152

 Parallel

126 (64.9)

34 (54.8)

  

 Not parallel

68 (35.1)

28 (45.2)

  

Margin

  

0.191

0.662

 Circumscribed

5 (2.6)

1 (1.6)

  

 Not circumscribed

189 (97.4)

61 (98.4)

  

Boundary

  

3.434

0.064

 Abrupt

140 (72.2)

37 (59.7)

  

 Halo

54 (27.8)

25 (40.3)

  

Echo pattern

  

2.338

0.505

 Hypoechoic

175 (90.2)

59 (95.2)

  

 Isoechoic

2 (1.0)

1 (1.6)

  

 Complex

15 (7.8)

2 (3.2)

  

 Hyperechoic

2 (1.0)

0 (0.0)

  

Posterior acoustic features

  

6.378

0.095

 No

47 (24.2)

14 (22.6)

  

 Enhancement

106 (54.7)

26 (41.9)

  

 Shadowing

34 (17.5)

20 (32.3)

  

 Combined

7 (3.6)

2 (3.2)

  

Calcifications

  

0.304

0.581

 No

111 (57.2)

33 (53.2)

  

 Yes

83 (42.8)

29 (46.8)

  

Vascular degree

  

0.174

0.986

 0

27 (13.9)

9 (14.5)

  

 I

25 (12.9)

9 (14.5)

  

 II

86 (44.3)

27 (43.6)

  

 III

56 (28.9)

17 (27.4)

  
  1. ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor-2, BMI body mass index, ALN axillary lymph node, US ultrasound